Showing results (2011-2020 of 3,477) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|August 19, 1999
Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patientsR Gieschke, B Fotteler, N Buss, et al.Clinical Pharmacokinetics|November 9, 2000
Clinical pharmacokinetics of ropiniroleC M Kaye, B NichollsClinical Pharmacokinetics|November 9, 2000
Pharmacokinetics of artemisinin-type compoundsV Navaratnam, S M Mansor, N W Sit, et al.Clinical Pharmacokinetics|November 9, 2000
Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactionsD A Flockhart, Z Desta, S K MahalClinical Pharmacokinetics|February 24, 2001
Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic eventsT HatanakaClinical Pharmacokinetics|February 24, 2001
Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depressionJ C FleishakerClinical Pharmacokinetics|January 5, 2001
Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteersC Brindley, C Falcoz, A E Mackie, et al.Clinical Pharmacokinetics|November 22, 2017
Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based ApproachHelena Colom, Franc Andreu, Teun van Gelder, et al.Clinical Pharmacokinetics|March 17, 2018
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing RegimensThomas Tängdén, Pier Giorgio Cojutti, Jason A Roberts, et al.Clinical Pharmacokinetics|December 18, 2018
Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell MalignanciesHelena Edlund, Sun Ku Lee, Marilee A Andrew, et al.Pageof 348